Correction to: Discovery of an Inhibitor of the Proteasome Subunit Rpn11 (Journal of Medicinal Chemistry (2017) 60 (1343�-1361) DOI: 10.1021/acs.jmedchem.6b01379));Discovery of an Inhibitor of the Proteasome Subunit Rpn11

Journal of Medicinal Chemistry

Volumn 60, Issue 4, 2017, Pages 1343-1361

  Perez, Christian ^a   Li, Jing ^b   Parlati, Francesco ^a,b,d   Rouffet, Matthieu ^e   Yuyong, M ^a   Mackinnon, Andrew L ^b   Chou, Tsui Fen ^b,c,f   Deshaies, Raymond J ^b   Cohen, Seth M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Institute of Technology   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^d Calithera Biosciences   (United States)

^e POINT LOMA NAZARENE UNIVERSITY   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 THIOQUINOLINE; 8,8' DISULFANEDIYLBIS(N (2 (THIAZOL 2 YL)ETHYL)QUINOLINE 3 CARBOXAMIDE); BORTEZOMIB; METALLOPROTEINASE; PROTEASOME; PROTEASOME INHIBITOR; RPN11 PROTEASOME INHIBITOR; RPN11 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; ZINC ION; PSMD14 PROTEIN, HUMAN; QUINOLINE DERIVATIVE; TRANSACTIVATOR PROTEIN; ZINC;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SELECTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROLYSIS; IC50; METAL BINDING; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL PROLIFERATION; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; METABOLISM; MOLECULAR MODEL; NEOPLASMS; TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DISCOVERY; HUMANS; MODELS, MOLECULAR; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; QUINOLINES; TRANS-ACTIVATORS; ZINC;

EID: 85013833905     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.7b00390     Document Type: Erratum

References (54)

1. Kyle, R. A.; Rajkumar, S. V. Treatment of Multiple Myeloma: A Comprehensive Review Clin. Lymphoma Myeloma 2009, 9 ( 4 ) 278-288 10.3816/CLM.2009.n.056
2. Survival Rates by Stage for Multiple Myeloma; American Cancer Society: Atlanta, 2016; http://www.cancer.org/cancer/multiplemyeloma/detailedguide/multiple-myeloma-survival-rates (accessed September 16, 2016).
3. Kisselev, A. F.; van der Linden, W. A.; Overkleeft, H. S. Proteasome Inhibitors: An Expanding Army Attacking a Unique Target Chem. Biol. 2012, 19 ( 1 ) 99-115 10.1016/j.chembiol.2012.01.003
4. Moreau, P.; Richardson, P. G.; Cavo, M.; Orlowski, R. Z.; San Miguel, J. F.; Palumbo, A.; Harousseau, J. L. Proteasome Inhibitors in Multiple Myeloma: 10 Years Later Blood 2012, 120 ( 5 ) 947-959 10.1182/blood-2012-04-403733
5. van der Linden, W. A.; Willems, L. I.; Shabaneh, T. B.; Li, N.; Ruben, M.; Florea, B. I.; van der Marel, G. A.; Kaiser, M.; Kisselev, A. F.; Overkleeft, H. S. Discovery of a Potent and Highly Beta 1 Specific Proteasome Inhibitor from a Focused Library of Urea-Containing Peptide Vinyl Sulfones and Peptide Epoxyketones Org. Biomol. Chem. 2012, 10 ( 1 ) 181-194 10.1039/C1OB06554H
6. Desvergne, A.; Genin, E.; Marechal, X.; Gallastegui, N.; Dufau, L.; Richy, N.; Groll, M.; Vidal, J.; Reboud-Ravaux, M. Dimerized Linear Mimics of a Natural Cyclopeptide (TMC-95A) Are Potent Noncovalent Inhibitors of the Eukaryotic 20S Proteasome J. Med. Chem. 2013, 56 ( 8 ) 3367-3378 10.1021/jm4002007
7. Geurink, P. P.; van der Linden, W. A.; Mirabella, A. C.; Gallastegui, N.; de Bruin, G.; Blom, A. E. M.; Voges, M. J.; Mock, E. D.; Florea, B. I.; van der Marel, G. A.; Driessen, C.; van der Stelt, M.; Groll, M.; Overkleeft, H. S.; Kisselev, A. F. Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites J. Med. Chem. 2013, 56 ( 3 ) 1262-1275 10.1021/jm3016987
8. Kawamura, S.; Unno, Y.; List, A.; Mizuno, A.; Tanaka, M.; Sasaki, T.; Arisawa, M.; Asai, A.; Groll, M.; Shuto, S. Potent Proteasome Inhibitors Derived from the Unnatural cis-Cyclopropane Isomer of Belactosin A: Synthesis, Biological Activity, and Mode of Action J. Med. Chem. 2013, 56 ( 9 ) 3689-3700 10.1021/jm4002296
9. Ozcan, S.; Kazi, A.; Marsilio, F.; Fang, B.; Guida, W. C.; Koomen, J.; Lawrence, H. R.; Sebti, S. M. Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome Inhibitors J. Med. Chem. 2013, 56 ( 10 ) 3783-3805 10.1021/jm400221d
10. Gallastegui, N.; Groll, M. The 26S proteasome: Assembly and Function of a Destructive Machine Trends Biochem. Sci. 2010, 35 ( 11 ) 634-642 10.1016/j.tibs.2010.05.005
11. Tanaka, K.; Mizushima, T.; Saeki, Y. The Proteasome: Molecular Machinery and Pathophysiological Roles Biol. Chem. 2012, 393 ( 4 ) 217-234 10.1515/hsz-2011-0285
12. Reyes-Turcu, F. E.; Wilkinson, K. D. Polyubiquitin Binding and Disassembly By Deubiquitinating Enzymes Chem. Rev. 2009, 109 ( 4 ) 1495-1508 10.1021/cr800470j
13. Koulich, E.; Li, X. H.; DeMartino, G. N. Relative Structural and Functional Roles of Multiple Deubiquitylating Proteins Associated With Mammalian 26S Proteasome Mol. Biol. Cell 2008, 19 ( 3 ) 1072-1082 10.1091/mbc.E07-10-1040
14. Guterman, A.; Glickman, M. H. Complementary Roles for Rpn11 and Ubp6 in Deubiquitination and Proteolysis by the Proteasome J. Biol. Chem. 2004, 279 ( 3 ) 1729-1738 10.1074/jbc.M307050200
15. Cenci, S.; Oliva, L.; Cerruti, F.; Milan, E.; Bianchi, G.; Raule, M.; Mezghrani, A.; Pasqualetto, E.; Sitia, R.; Cascio, P. Pivotal Advance: Protein Synthesis Modulates Responsiveness of Differentiating and Malignant Plasma Cells to Proteasome Inhibitors J. Leukocyte Biol. 2012, 92 ( 5 ) 921-931 10.1189/jlb.1011497
16. Deshaies, R. J. Proteotoxic Crisis, the Ubiquitin-Proteasome System, and Cancer Therapy BMC Biol. 2014, 12, 94 10.1186/s12915-014-0094-0
17. McCullough, J.; Clague, M. J.; Urbe, S. AMSH is an Endosome-Associated Ubiquitin Isopeptidase J. Cell Biol. 2004, 166 ( 4 ) 487-492 10.1083/jcb.200401141
18. Nijman, S. M. B.; Luna-Vargas, M. P. A.; Velds, A.; Brummelkamp, T. R.; Dirac, A. M. G.; Sixma, T. K.; Bernards, R. A Genomic and Functional Inventory of Deubiquitinating Enzymes Cell 2005, 123 ( 5 ) 773-786 10.1016/j.cell.2005.11.007
19. Zhu, P.; Zhou, W. L.; Wang, J. X.; Puc, J.; Ohgi, K. A.; Erdjument-Bromage, H.; Tempst, P.; Glass, C. K.; Rosenfeld, M. G. A Histone H2A Deubiquitinase Complex Coordinating Histone Acetylation and H1 Dissociation in Transcriptional Regulation Mol. Cell 2007, 27 ( 4 ) 609-621 10.1016/j.molcel.2007.07.024
20. Ambroggio, X. I.; Rees, D. C.; Deshaies, R. J. JAMM: A Metalloprotease-like Zinc Site in the Proteasome and Signalosome PLoS Biol. 2003, 2 ( 1 ) e2 10.1371/journal.pbio.0020002
21. Sobhian, B.; Shao, G. Z.; Lilli, D. R.; Culhane, A. C.; Moreau, L. A.; Xia, B.; Livingston, D. M.; Greenberg, R. A. RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites Science 2007, 316 ( 5828 ) 1198-1202 10.1126/science.1139516
22. Cope, G. A.; Suh, G. S. B.; Aravind, L.; Schwarz, S. E.; Zipursky, S. L.; Koonin, E. V.; Deshaies, R. J. Role of Predicted Metalloprotease Motif of Jab1/Csn5 in Cleavage of Nedd8 From Cul1 Science 2002, 298 ( 5593 ) 608-611 10.1126/science.1075901
23. Sato, Y.; Yoshikawa, A.; Yamagata, A.; Mimura, H.; Yamashita, M.; Ookata, K.; Nureki, O.; Iwai, K.; Komada, M.; Fukai, S. Structural Basis for Specific Cleavage of Lys 63-Linked Polyubiquitin Chains Nature 2008, 455 ( 7211 ) 358-362 10.1038/nature07254
24. Shrestha, R. K.; Ronau, J. A.; Davies, C. W.; Guenette, R. G.; Strieter, E. R.; Paul, L. N.; Das, C. Insights into the Mechanism of Deubiquitination by JAMM Deubiquitinases from Cocrystal Structures of the Enzyme with the Substrate and Product Biochemistry 2014, 53 ( 19 ) 3199-3217 10.1021/bi5003162
25. Li, J.; Yakushi, T.; Parlati, F.; Mackinnon, A. L.; Perez, C.; Ma, Y.; Carter, K. P.; Colayco, S.; Magnuson, G.; Brown, B.; Nguyen, K.; Vasile, S.; Suyama, E.; Smith, L. H.; Sergienko, E.; Pinkerton, A. B.; Chung, T. D. Y.; Palmer, A.; Pass, I.; Hess, S.; Cohen, S. M.; Deshaies, R. J. Capzimin is a Potent and Specific Inhibitor of Proteasome Isopeptidase Rpn11. Nat. Chem. Biol. 2017, in press.
26. Kisselev, A. F.; Goldberg, A. L. Proteasome Inhibitors: From Research Tools to Drug Candidates Chem. Biol. 2001, 8 ( 8 ) 739-758 10.1016/S1074-5521(01)00056-4
27. Adams, J. The Development of Proteasome Inhibitors as Anticancer Drugs Cancer Cell 2004, 5 ( 5 ) 417-421 10.1016/S1535-6108(04)00120-5
28. Crawford, L. J.; Walker, B.; Irvine, A. E. Proteasome Inhibitors in Cancer Therapy J. Cell Commun. Signal. 2011, 5 ( 2 ) 101-110 10.1007/s12079-011-0121-7
29. Lim, H. S.; Archer, C. T.; Kodadek, T. Identification of a Peptoid Inhibitor of the Proteasome 19S Regulatory Particle J. Am. Chem. Soc. 2007, 129 ( 25 ) 7750-7751 10.1021/ja072027p
30. Lim, H. S.; Cai, D.; Archer, C. T.; Kodadek, T. Periodate-Triggered Cross-Linking Reveals Sug2/Rpt4 as the Molecular Target of a Peptoid Inhibitor of the 19S Proteasome Regulatory Particle J. Am. Chem. Soc. 2007, 129 ( 43 ) 12936-12937 10.1021/ja075469+
31. Trader, D. J.; Simanski, S.; Kodadek, T. A Reversible and Highly Selective Inhibitor of the Proteasomal Ubiquitin Receptor Rpn13 Is Toxic to Multiple Myeloma Cells J. Am. Chem. Soc. 2015, 137 ( 19 ) 6312-6319 10.1021/jacs.5b02069
32. Anchoori, R. K.; Karanam, B.; Peng, S. W.; Wang, J. W.; Jiang, R.; Tanno, T.; Orlowski, R. Z.; Matsui, W.; Zhao, M.; Rudek, M. A.; Hung, C. F.; Chen, X.; Walters, K. J.; Roden, R. B. S. A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer Cancer Cell 2013, 24 ( 6 ) 791-805 10.1016/j.ccr.2013.11.001
33. Tian, Z.; D’Arcy, P.; Wang, X.; Ray, A.; Tai, Y. T.; Hu, Y. G.; Carrasco, R. D.; Richardson, P.; Linder, S.; Chauhan, D.; Anderson, K. C. A Novel Small Molecule Inhibitor of Deubiquitylating Enzyme USP14 and UCHL5 Induces Apoptosis in Multiple Myeloma and Overcomes Bortezomib Resistance Blood 2014, 123 ( 5 ) 706-716 10.1182/blood-2013-05-500033
34. Jacobsen, J. A.; Fullagar, J. L.; Miller, M. T.; Cohen, S. M. Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach J. Med. Chem. 2011, 54 ( 2 ) 591-602 10.1021/jm101266s
35. Garner, A. L.; Struss, A. K.; Fullagar, J. L.; Agrawal, A.; Moreno, A. Y.; Cohen, S. M.; Janda, K. D. 3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB ACS Med. Chem. Lett. 2012, 3 ( 8 ) 668-672 10.1021/ml300128f
36. Fullagar, J. L.; Garner, A. L.; Struss, A. K.; Day, J. A.; Martin, D. P.; Yu, J.; Cai, X. Q.; Janda, K. D.; Cohen, S. M. Antagonism of a Zinc Metalloprotease Using a Unique Metal-Chelating Scaffold: Tropolones as Inhibitors of P. aeruginosa Elastase Chem. Commun. 2013, 49 ( 31 ) 3197-3199 10.1039/c3cc41191e
37. uHTS Identification of Inhibitors of Rpn11 in a Fluorescent Polarization Assay. PubChem BioAssay Database; AID = 588493; National Center for Biotechnology Information: Bethesda, MD, 2012; https://pubchem.ncbi.nlm.nih.gov/bioassay/588493 (accessed September 16, 2016).
38. uHTS Identification of Small Molecule Inhibitors of Csn-Mediated Deneddylation of Cullin-Ring Ligases, vis a Fluorescence Polarization Assay. PubChem BioAssay Database; AID = 651999; National Center for Biotechnology Information: Bethesda, MD, 2013; https://pubchem.ncbi.nlm.nih.gov/bioassay/651999 (accessed September 16, 2016).
39. Hopkins, A. L.; Groom, C. R.; Alex, A. Ligand Efficiency: A Useful Metric for Lead Selection Drug Discovery Today 2004, 9 ( 10 ) 430-431 10.1016/S1359-6446(04)03069-7
40. Borgneczak, K.; Tjalve, H. Effect of 8-Hydroxy-Quinoline, 8-Mercapto-Quinoline and 5-Chloro-7-Iodo-8-Hydroxy-Quinoline on the Uptake and Distribution of Nickel in Mice Pharmacol. Toxicol. 1994, 74 ( 3 ) 185-192 10.1111/j.1600-0773.1994.tb01097.x
41. Prachayasittikul, V.; Prachayasittikul, S.; Ruchirawat, S.; Prachayasittikul, V. 8-Hydroxyquinolines: A Review of Their Metal Chelating Properties and Medicinal Applications Drug Des., Dev. Ther. 2013, 7, 1157-1178 10.2147/DDDT.S49763
42. Su, C. Y.; Liao, S.; Wanner, M.; Fiedler, J.; Zhang, C.; Kang, B. S.; Kaim, W. The Copper(I)/Copper(II) Transition in Complexes With 8-Alkylthioquinoline Based Multidentate Ligands Dalton Trans. 2003, 2, 189-202 10.1039/b208120m
43. Puerta, D. T.; Cohen, S. M. Elucidating Drug-Metalloprotein Interactions with Tris(pyrazolyl)borate Model Complexes Inorg. Chem. 2002, 41 ( 20 ) 5075-5082 10.1021/ic0204272
44. Bridgewater, B. M.; Parkin, G. Lead Poisoning and the inactivation of 5-Aminolevulinate Dehydratase as Modeled by the Tris(2-mercapto-1-phenylimidazolyl)hydroborato Lead Complex, {[Tm-Ph]Pb}[ClO4] J. Am. Chem. Soc. 2000, 122 ( 29 ) 7140-7141 10.1021/ja001530y
45. Hammes, B. S.; Carrano, C. J. Methylation of (2-Methylethanethiol-bis-3,5-dimethylpyrazolyl)methane Zinc Complexes and Coordination of the Resulting Thioether: Relevance to Zinc-Containing Alkyl Transfer Enzymes Inorg. Chem. 2001, 40 ( 5 ) 919-927 10.1021/ic001178p
46. Trofimenko, S. Recent Advances in Poly(Pyrazolyl)Borate (Scorpionate) Chemistry Chem. Rev. 1993, 93 ( 3 ) 943-980 10.1021/cr00019a006
47. Tesmer, M.; Shu, M. H.; Vahrenkamp, H. Sulfur-Rich Zinc Chemistry: New Tris(thioimidazolyl)hydroborate Ligands and Their Zinc Complex Chemistry Related to the Structure and Function of Alcohol Dehydrogenase Inorg. Chem. 2001, 40 ( 16 ) 4022-4029 10.1021/ic0101275
48. Vahrenkamp, H. Transitions, Transition Sstates, Transition State Analogues: Zinc Pyrazolylborate Chemistry Related to Zinc Enzymes Acc. Chem. Res. 1999, 32 ( 7 ) 589-596 10.1021/ar9703185
49. Duda, D. M.; Borg, L. A.; Scott, D. C.; Hunt, H. W.; Hammel, M.; Schulman, B. A. Structural Insights Into NEDD8 Activation of Cullin-RING Ligases: Conformational Control of Conjugation Cell 2008, 134 ( 6 ) 995-1006 10.1016/j.cell.2008.07.022
50. Chou, T. F.; Deshaies, R. J. Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System J. Biol. Chem. 2011, 286 ( 19 ) 16546-16554 10.1074/jbc.M110.215319
51. Davies, C. W.; Paul, L. N.; Kim, M. I.; Das, C. Structural and Thermodynamic Comparison of the Catalytic Domain of AMSH and AMSH-LP: Nearly Identical Fold but Different Stability J. Mol. Biol. 2011, 413 ( 2 ) 416-429 10.1016/j.jmb.2011.08.029
52. Puerta, D. T.; Griffin, M. O.; Lewis, J. A.; Romero-Perez, D.; Garcia, R.; Villarreal, F. J.; Cohen, S. M. Heterocyclic Zinc-Binding Groups for Use in Next-Generation Matrix Metalloproteinase Inhibitors: Potency, Toxicity, and Reactivity JBIC, J. Biol. Inorg. Chem. 2006, 11 ( 2 ) 131-138 10.1007/s00775-005-0053-x
53. Pufahl, R. A.; Kasten, T. P.; Hills, R.; Gierse, J. K.; Reitz, B. A.; Weinberg, R. A.; Masferrer, J. L. Development of a Fluorescence-Based Enzyme Assay of Human 5-Lipoxygenase Anal. Biochem. 2007, 364 ( 2 ) 204-212 10.1016/j.ab.2007.02.009
54. Martin, D. P.; Hann, Z. S.; Cohen, S. M. Metalloprotein-Inhibitor Binding: Human Carbonic Anhydrase II as a Model for Probing Metal-Ligand Interactions in a Metalloprotein Active Site Inorg. Chem. 2013, 52 ( 21 ) 12207-12215 10.1021/ic400295f